Pharmaceutical
Home » Cryptococcosis Market

Cryptococcosis Market

Cryptococcosis Market By Treatment (Amphotericin B, Flucytosine, Fluconazole) – Growth, Future Prospects And Competitive Analysis 2017 – 2025
Report Book

Published Date: May 2017
Category: Pharmaceuticals
Report ID: 58453
Report Format: PDF
No of Pages: 190

Rating: Credence Reports

Market Insights

Cryptococcosis is a potentially fatal fungal infection caused by the fungus Cryptococcus. Factors such as the increase in the prevalence of fatal fungal diseases, rising treatment awareness, and last-stage HIV patients developing the disease are driving the growth of the cryptococcosis market worldwide.

The report titled “Cryptococcosis Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall Cryptococcosis market, along with the market size and estimates for the duration of 2015–2025. The research study covers an in-depth analysis of market segments based on treatment type (Amphotericin B, Flucytosine, Fluconazole, and Other Treatment Options) and different geographical regions.

In order to help strategic decision-makers, the report also includes sections on the competitive profiling of the leading players in the global cryptococcosis market, an attractive investment proposition, and the market positioning of key manufacturers.

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global cryptococcosis market.

Tools such as market positioning of key players and appealing investment propositions provide readers with insights into the global cryptococcosis market’s competitive scenario. This report concludes with a company profiles section that highlights major information about the key players engaged in the global cryptococcosis market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global cryptococcal market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Based on treatment type, the global cryptococcosis market is segmented as follows:

  • Amphotericin B
  • Fluconazole
  • Flucytosine
  • Others (Voriconazole, surgery treatment, etc.)

Cryptococcosis is a disease caused by a species of fungus. Factors such as the increasing prevalence of fatal fungal diseases, advances in treatment options, and the fact that HIV-infected patients are at higher risk of developing fungal diseases are driving the growth of the cryptococcosis market worldwide.

Cryptococcus neoformans is the main cause of disease; it is rare among healthy individuals; however, it is a major cause of illness in HIV-infected patients. According to the Centers for Disease Control and Prevention (CDC), 1 million cases of cryptococcal meningitis occur among HIV-infected patients worldwide each year. In general, cryptococcosis treatment is divided into three stages: induction, consolidation, and maintenance.

During induction therapy, Amphotericin B and Flucytosine are the most commonly used treatment regimens on the market. Fluconazole and itraconazole are part of a treatment regimen given for at least eight weeks after the successful completion of 2 weeks of induction therapy. Fluconazole appears to be the preferred regimen for at least one year of maintenance therapy. Flucytosine was the leading revenue contributor in the global cryptococcosis market in 2016 due to factors such as the fact that Flucytosine is responsible for reducing fungal burden in the brain, spleen, and lungs and is also used as the first-line treatment for cryptococcosis infection.

For the purpose of this study, the global cryptococcosis market is categorized into three segments:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

The major causes of cryptococcosis are infections by C. neoformans and C. gattii. It is observed that approximately 5 to 8% of HIV-infected patients in developed countries develop cryptococcosis. According to the Centers for Disease Control and Prevention (CDC), approximately 1 million cases of cryptococcal meningitis occur every year among patients infected with HIV.

In the base year 2016, North America dominated the cryptococcosis market in terms of revenue due to factors such as higher drug costs, an upsurge in funding by government agencies and private organizations in the healthcare system, an increase in the incidence of fungal infections in endemic areas of North America, and higher investments in research and development that are driving the market growth in North America.

Europe is the second largest revenue-generating region for the cryptococcal market because technological advances, developed healthcare infrastructure, and the higher cost of medication are influencing the market’s growth in Europe. Because the number of HIV-infected patients in the Middle East and Africa is extremely high, and there is an increase in demand for cryptococcal medication, the market is expected to grow significantly during the forecast period. However, factors such as the comparatively lower cost of treatment medication may hinder the growth of the cryptococcosis market in the Middle East and Africa.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Cryptococcosis Market Snapshot
2.2 Global Cryptococcosis Market, by Treatment Type, 2016 (US$ Bn)
2.3 Global Cryptococcosis Market Share, by Geography, 2016 (Value %)

Chapter 3 Cryptococcosis Market Analysis
3.1 Global Cryptococcosis Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Significant Unmet Need
3.2.1.2 High prevalence of Cryptococcosis and other fungal diseases
3.2.2 Challenges
3.2.2.1 Poor Patient Compliance in some countries
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Cryptococcosis Market

Chapter 4 Global Cryptococcosis Market, by Treatment Type
4.1 Overview
4.2 Amphotericin B
4.3 Flucytosine
4.4 Fluconazole
4.5 Other (Voriconazole, surgery treatment, etc.)

Chapter 5 Global Cryptococcosis Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.5 Latin America
5.6 Middle East and Africa

Chapter 6 Company Profiles
6.1 Abbott Laboratories
6.2 Alkopharma Inc.
6.3 Astellas Pharma Inc.
6.4 Bristol-Myers Squibb Company
6.5 Glenmark Pharmaceuticals
6.6 Janssen Biotech, Inc. (a Johnson & Johnson)
6.7 Novartis AG
6.8 Pfizer Inc.
6.9 Sigmapharm Laboratories LLC.
6.10 Valeant Pharmaceuticals, Inc.

List of Figures

FIG. 1 Cryptococcosis Market: Research Methodology
FIG. 2 Global Cryptococcosis Market, by Treatment Type, 2016 (US$ Bn)
FIG. 3 Global Cryptococcosis Market Share, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition: Global Cryptococcosis Market, by Geography, 2016
FIG. 1 Global Amphotericin B Market for Cryptococcosis, 2015 – 2025 (US$ Bn)
FIG. 1 Global Flucytosine Market for Cryptococcosis, 2015 – 2025 (US$ Bn)
FIG. 1 Global Fluconazole Market for Cryptococcosis, 2015 – 2025 (US$ Bn)
FIG. 1 Global Other (Voriconazole, surgery treatment) Market for Cryptococcosis, 2015 – 2025 (US$ Bn)
FIG. 2 Latin America Cryptococcosis Market, 2015 – 2025 (US$ Bn)
FIG. 3 Middle East and Africa Cryptococcosis Market, 2015 – 2025 (US$ Bn)

List of Tables

TABLE 1 Market Positioning of Key Players in Global Cryptococcosis Market
TABLE 2 Global Cryptococcosis Market, by Treatment Type, 2015 – 2025 (US$ Bn)
TABLE 3 Global Cryptococcosis Market, by Geography, 2015 – 2025 (US$ Bn)
TABLE 4 North America Cryptococcosis Market, 2015 – 2025 (US$ Bn)
TABLE 5 Europe Cryptococcosis Market, 2015 – 2025 (US$ Bn)
TABLE 6 Asia Pacific Cryptococcosis Market, 2015 – 2025 (US$ Bn)
TABLE 7 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 8 Alkopharma INC.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 9 Astellas Pharma INC.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 10 Bristol-Myers Squibb Company: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 11 Glenmark Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 12 Janssen Biotech, Inc. (a Johnson & Johnson): Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 13 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 14 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 15 Sigmapharm Laboratories LLC.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 16 Valeant Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)

Frequently Asked Question:

What is the size of Cryptococcosis Market?

The market for Cryptococcosis Market is expected to reach USD$ 6.76 Bn in 2025.

What is the Cryptococcosis Market CAGR?

The Cryptococcosis Market is expected to see significant CAGR growth over the coming years, at 4.5%.

What is the Forecast period considered for Cryptococcosis Market?

The report is forecasted from 2017 -2025.

What is the base year considered for Cryptococcosis Market?

The base year of this report is 2016.

Who are the major players in this market?

Abbott Laboratories, Alkopharma Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Glenmark Pharmaceuticals. are some of the major players in the global market.

Healthcare

Trientine Hydrochloride Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 58081
Report Format: PDF
No of Pages: 247

Pharmaceutical

Pharmaceutical Chemicals Market

Published Date: Sept 2023
Category: Pharmaceuticals
Report ID: 62118
Report Format: PDF
No of Pages: 247

Pharmaceutical

Wilson’s Disease Drugs Market

Published Date: Sept 2023
Category: Pharmaceuticals
Report ID: 58947
Report Format: PDF
No of Pages: 190

Healthcare

Stretch Marks Treatment Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62116
Report Format: PDF
No of Pages: 221

Pharmaceutical

Fetal Bovine Serum Market

Published Date: Sept 2023
Category: Pharmaceuticals
Report ID: 62115
Report Format: PDF
No of Pages: 238

Healthcare

Cirrhosis Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62114
Report Format: PDF
No of Pages: 229

Pharmaceutical

Congenital Hyperinsulinism Treatment Market

Published Date: Sept 2023
Category: Pharmaceuticals
Report ID: 62113
Report Format: PDF
No of Pages: 219

Healthcare

Cryptococcal Meningitis Treatment Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62112
Report Format: PDF
No of Pages: 237

Healthcare

Dermatology Endoscopy devices Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62111
Report Format: PDF
No of Pages: 237

Healthcare

Cementless Total Knee Arthroplasty Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62110
Report Format: PDF
No of Pages: 228

Healthcare

Cell & Gene Therapy Clinical Trials Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62109
Report Format: PDF
No of Pages: 228

HealthCare

Self-sampling Blood Collection and Storage Device Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 61352
Report Format: PDF
No of Pages: 234

Download Sample Report


Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN
WhatsApp Now